—#181527

Product

VITROS Chemistry Product Performance Verifier II, Product Code 8067324, UDI # 10758750004317 - Product Usage: For in vitro diagnostic use only to quantitatively measure amylase activity in serum, plasma, and urine using VITROS 250/350/5, 1 FS/4600/XT 3400 Chemistry Systems and VITROS 5600/XT 7600 Integrated Systems.

FDA product code: CIW — Starch-Dye Bound Polymer, Amylase
Device class: Class 2
Medical specialty: Clinical Chemistry
510(k) numbers: K812027
Affected lot / code info: Current Control Assay Sheet SD 10.5, 10.8 Revised Control Assay Sheet 17.1, 17.6

Why it was recalled

Multiple coatings of VITROS Chemistry Products AMYL Slides are showing imprecision on control fluids when compared to the expected within lab SD as listed on the Performance Verifier (PV) Assay Sheets.

Root cause (FDA determination)

Under Investigation by firm

Action the firm took

On May 11, 2020, Ortho Clinical Diagnostics, Inc. sent an Urgent Medical Device Correction Notification to their customers alerting them of important information regarding the precision of VITROS AMYL Slides. The notice stated that the imprecision affects serum, urine and QC samples, however VITROS AMYL Slides performance continues to meet its intended clinical use. The VITROS Performance Verifiers I and II Control Assay Sheet estimated within-lab SD, Range of Means (ROM) and Delta table values were re-evaluated. The Delta tables will be updated in a future revision of the Performance Verifier Training Module. In the meantime, customers were instructed to use the revised estimated within-lab SD listed in the enclosed Information sheet to evaluate their lab's quality control when using VITROS Performance Verifier I and II products. When available on the Ortho website, https://www.orthoclinicaldiagnostics.com, customers can obtain the updated VITROS Performance Verifier Control Assay Sheets and can use the revised ROM to evaluate the labs VITROS AMYL Slide quality control when using VITROS Performance Verifier I and II products. The firm explained that a review of previously reported patient results is NOT recommended. The customers were asked to Complete the Confirmation of Receipt form no later than May 19, 2020 and to forward the notification if the product was distributed outside of their facility.

Recalling firm

Firm: Ortho-Clinical Diagnostics
Address: 513 Technology Blvd, Rochester, New York 14626-3601

Distribution

Distribution pattern: Worldwide distribution - US Nationwide including in the statesof Maine, Massachusetts, Vermont, Connecticut, New Jersey, New York, Pennsylvania, Washington DC, Maryland, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Alabama, Tennessee, Missouri, Mississippi, Kentucky, Ohio, Indiana, Michigan, Iowa, Wisconsin, Minnesota, South Dakota, North Dakota, Montana, Illinois, Kansas, Nebraska, Louisiana, Arkansas, Oklahoma, Texas, Colorado, Idaho, Utah, Arizona, New Mexico, California, Hawaii, Oregon , Washington, and Alaska

Timeline

Recall initiated: 2020-05-11
Terminated: 2021-09-22
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #181527. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.